ARCHIVES

NCI Bypass Budget Justifies An Extra $900 Million In FY1992; Cancer costs Estimate At $80B A Year

This article is from The Cancer Letter archive.

Vol. 17 No. 02 | January 11, 1991

Download PDF Visit The Full Archive

Related Articles

Study Finds Gene Expression Test Predicts Stage I or II Recurrence

August 30, 2013

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

December 19, 2014

ORI Withdraws Requirement For Research Ethics Courses.

February 23, 2001

Obituary: Carl Baker, Former NCI Director

March 13, 2009

Lymphatic Mapping Techniques Can Outperform “Watch-and-Wait”

February 28, 2014

Funding Opportunities: March 1 Deadline For ACS Fellowships; Program Announcements

January 23, 1998